Syndax Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. IBM
9. HOOD
10. DFTX

Go back to Syndax Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 2c

May 6, 2019 4:35 PM EDT

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.53), $0.02 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $379 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

... More